KE3405A - Improvements in or relating to spirocyclic compounds - Google Patents

Improvements in or relating to spirocyclic compounds

Info

Publication number
KE3405A
KE3405A KE3405A KE340584A KE3405A KE 3405 A KE3405 A KE 3405A KE 3405 A KE3405 A KE 3405A KE 340584 A KE340584 A KE 340584A KE 3405 A KE3405 A KE 3405A
Authority
KE
Kenya
Prior art keywords
relating
spirocyclic compounds
spirocyclic
compounds
Prior art date
Application number
KE3405A
Other languages
English (en)
Inventor
Berthold Richard
G Payne Trevor
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of KE3405A publication Critical patent/KE3405A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/38Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/93Spiro compounds
    • C07C2603/94Spiro compounds containing "free" spiro atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KE3405A 1976-05-14 1984-04-19 Improvements in or relating to spirocyclic compounds KE3405A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH606376A CH621330A5 (no) 1976-05-14 1976-05-14

Publications (1)

Publication Number Publication Date
KE3405A true KE3405A (en) 1985-02-01

Family

ID=4303639

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3405A KE3405A (en) 1976-05-14 1984-04-19 Improvements in or relating to spirocyclic compounds

Country Status (26)

Country Link
US (1) US4322437A (no)
JP (1) JPS52139051A (no)
AT (1) AT362349B (no)
AU (1) AU513066B2 (no)
BE (1) BE854567A (no)
CA (1) CA1095913A (no)
CH (1) CH621330A5 (no)
CY (1) CY1226A (no)
DE (1) DE2719871A1 (no)
DK (1) DK197677A (no)
ES (1) ES458724A1 (no)
FI (1) FI771427A (no)
FR (1) FR2351091A1 (no)
GB (1) GB1576034A (no)
HK (1) HK35984A (no)
IE (1) IE44950B1 (no)
IL (1) IL52072A (no)
KE (1) KE3405A (no)
NL (1) NL7705128A (no)
NZ (1) NZ184079A (no)
PH (1) PH14176A (no)
PT (1) PT66540B (no)
SE (1) SE7705221L (no)
SG (1) SG84983G (no)
SU (1) SU634663A3 (no)
ZA (1) ZA772873B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2810869A1 (de) * 1977-03-24 1978-09-28 Sandoz Ag 3-amino-2-hydroxypropoxy-derivate, ihre herstellung und verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641152A (en) * 1949-07-15 1953-06-09 Herbert M Hise Stringed musical instrument
GB1046001A (en) * 1964-03-12 1966-10-19 Ici Ltd Propanolamine derivatives
US3839415A (en) * 1965-10-22 1974-10-01 Lilly Co Eli 2-halo-1-(alkyl-1-(alkylamino)ethyl)vinyl benzoic acid esters and derivatives
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines
CH554314A (de) * 1969-06-03 1974-09-30 Sandoz Ag Verfahren zur herstellung neuer fluorenone.
BE755071A (fr) * 1969-09-17 1971-02-22 Warner Lambert Pharmaceutical Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone

Also Published As

Publication number Publication date
SU634663A3 (ru) 1978-11-25
CH621330A5 (no) 1981-01-30
FR2351091A1 (fr) 1977-12-09
FR2351091B1 (no) 1980-01-18
AT362349B (de) 1981-05-11
SE7705221L (sv) 1977-11-15
AU2514077A (en) 1978-11-16
DK197677A (da) 1977-11-15
IE44950L (en) 1977-11-14
DE2719871A1 (de) 1977-12-01
BE854567A (fr) 1977-11-14
IE44950B1 (en) 1982-05-19
NZ184079A (en) 1978-09-25
IL52072A (en) 1980-10-26
NL7705128A (nl) 1977-11-16
PT66540A (fr) 1977-06-01
FI771427A (no) 1977-11-15
IL52072A0 (en) 1977-07-31
AU513066B2 (en) 1980-11-13
ES458724A1 (es) 1978-08-01
PH14176A (en) 1981-03-19
GB1576034A (en) 1980-10-01
CA1095913A (en) 1981-02-17
SG84983G (en) 1985-01-11
PT66540B (fr) 1979-10-22
US4322437A (en) 1982-03-30
JPS52139051A (en) 1977-11-19
ATA343577A (de) 1980-10-15
CY1226A (en) 1984-04-06
HK35984A (en) 1984-05-04
ZA772873B (en) 1978-12-27

Similar Documents

Publication Publication Date Title
GR65229B (en) Improvements in or relating to organic compounds
ZA775905B (en) Improvements relating to 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes
ZA774277B (en) Improvements in or relating to organic compounds
MY8400057A (en) Improvements in or relating to organic compounds
ZA774778B (en) Improvements in or relating to glycerokinases
ZA77151B (en) Improvements in or relating to organic compounds
ZA775816B (en) Improvements relating to pyridobenzodiazepinones
ZA775818B (en) Improvements in or relating to organic compounds
ZA774654B (en) Improvements in or relating to dartboards
ZA77579B (en) Improvements in or relating to organic compounds
ZA776138B (en) Improvements in or relating to organic compounds
ZA775687B (en) Improvements in or relating to organic compounds
ZA771148B (en) Improvements in or relating to organic compounds
ZA767715B (en) Improvements in or relating to organic compounds
ZA773428B (en) Improvements in or relating to organic compounds
ZA772935B (en) Improvements in or relating to organic compounds
ZA777425B (en) Improvements in or relating to organic compounds
ZA77510B (en) Improvements in or relating to organic compounds
ZA77742B (en) Improvements in or relating to organic compounds
KE3405A (en) Improvements in or relating to spirocyclic compounds
ZA77511B (en) Improvements in or relating to organic compounds
ZA767714B (en) Improvements in or relating to organic compounds
ZA773251B (en) Improvements in or relating to organic compounds
ZA767716B (en) Improvements in or relating to organic compounds
ZA777491B (en) Improvements in or relating to organic compounds